Skip to main content
. Author manuscript; available in PMC: 2016 Jun 1.
Published in final edited form as: Birth Defects Res A Clin Mol Teratol. 2015 Apr 17;103(6):517–526. doi: 10.1002/bdra.23378

TABLE 1.

Neural tube defect (NTD) risk category by red blood cell (RBC) folate concentrations for different blood folate assay methods1

Risk category NTD prevalence per
10,000 live births2
RBC folate concentration (nmol/L)
Molloy method Pfeiffer/NHANES
method3
High >14 ≤699 ≤585
Elevated 9 – 14 700 – 905 586 – 747
Optimal 4 – <9 906 – 1499 748 – 1215
Limited additional benefit Outside of estimable range ≥1500 ≥1216
1

Derived from Crider et al., 2014 (1) and Daly et al., 1995 (2)

2

NTD prevalence estimates are based on the median estimated NTD prevalence for an entire population with a given RBC folate concentration, corresponding to the risk category cut points; rounded to the nearest whole number

3

To convert from Molloy method to Pfeiffer/NHANES method, the following conversion formula should be used: Pfeiffer/NHANES RBC folate [nmol/L] = (Molloy RBC folate [nmol/L] * 0.7876) + 34.2802 [nmol/L] (1)